National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

deferasirox
A synthetic, orally bioavailable, achiral, tridentate triazole derived from salicylic acid with iron-chelating activity. Deferasirox chelates iron at a 2:1 (ligand:iron) ratio. Because of its oral availablity,and long plasma half-life, this agent may be superior to desferrioxamine (desferal, DFO), which is orally inactive and has a short plasma half-life. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Exjade
Code name:ICL670



Previous:Decadron, Decasone R.p., Decaspray, decitabine, Deenar
Next:deferoxamine mesylate, defibrotide, defined green tea catechin extract, Definity, deforolimus

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov